evidence table
Nattokinase Blood Pressure Meta-Analysis Evidence Table
Structured evidence table for Nattokinase Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Nattokinase Blood Pressure Meta-Analysis | In order to reduce the risk of thrombosis, patients with atherosclerotic cardiovascular disease are often prescribed antiplatelet therapy. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Nattokinase Blood Pressure Meta-Analysis | Nevertheless, platelet aggregation inhibition can also result in an increased bleeding risk, which is why the clinical approach must consider the benefit of single or dual antiplatelet treatments. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Nattokinase Blood Pressure Meta-Analysis | The bleeding risk in atherosclerosis can arise from plaque rupture or the presence of intraplaque hemorrhage. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Nattokinase Blood Pressure Meta-Analysis | 1 2 3 The development of atherosclerosis, an essential promoter of cardiovascular diseases and stroke via thrombus formation [], is supported by the interplay between platelets and endothelial cells []. | 3 | Dobre Maria-Zinaida (2025) | Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks |
| Nattokinase Blood Pressure Meta-Analysis | Familial hypercholesterolemia is due to LDLR, PCSK9, and APOB gene mutations that cause LDL clearance disorders, and ultimately LDL-C is significantly increased; familial mixed hyperlipidemia is a polygenic inheritance that leads to an increase in LDL and VLDL levels in the body, resulting in excessive TC and TG levels. | 3 | Wei Chuyang (2025) | Research Progress of Nattokinase in Reducing Blood Lipid |
| Nattokinase Blood Pressure Meta-Analysis | In addition, it may also improve vascular endothelial function by inhibiting inflammatory factors such as TNF-α and IL-6, and indirectly reduce the risk of thrombosis. | 3 | Wei Chuyang (2025) | Research Progress of Nattokinase in Reducing Blood Lipid |
| Nattokinase Blood Pressure Meta-Analysis | During the NK purification process, the traditional protein expression and purification technology were changed and improved for better activity, but the results were less useful []. | 3 | Wei Chuyang (2025) | Research Progress of Nattokinase in Reducing Blood Lipid |
| Nattokinase Blood Pressure Meta-Analysis | According to the World Health Organization, about 18 million people die of CVD every year, accounting for more than 30% of all deaths worldwide []. | 3 | Wei Chuyang (2025) | Research Progress of Nattokinase in Reducing Blood Lipid |
Source documents